Details

Product Name in the RMS: Numeta G13E

MR Number: SE/H/0918/004
Date of outcome: 15.03.2016

Type of application
Level 1: Level 2: Level 3: Level 4: Level 5:	Line Extension Additional Strength/Form Fixed Combination Chemical Substance Prescription Only
Active Substances	alanine 4,66 g arginine 4,89 g aspartic acid 3,5 g calcium chloride dihydrate 3,45 g cysteine 1,1 g glucose monohydrate 550 g glutamic acid 5,83 g glycine 2,33 g histidine 2,21 g isoleucine 3,9 g leucine 5,83 g lysine 6,41 g MAGNESIUM ACETATE tetrahydrate 0,63 g methionine 1,4 g ornithine 1,45 g phenylalanine 2,45 g potassium acetate 3,83 g proline 1,75 g serine 2,33 g sodium glycerophosphate hydrate 6,15 g taurine 0,35 g threonine 2,16 g tryptophan 1,17 g tyrosine 0,45 g valine 4,43 g
Form	Emulsion for infusion
MA Holder in the RMS	Baxter Medical AB, Sweden
RMS	Sweden
Date of last change	28.12.2020
ATC-Code	B05BA10 Combinations

CMS Country	Domestic Product Name
Austria	Numeta G 13 % E Emulsion zur Infusion
Belgium	Numetzah G13%E émulsion pour perfusion
Czech Republic	Numeta G13%E
Denmark	Numeta G13E
Finland
France
Germany	Numeta G 13 % E
Greece	NUMETA® PRETERM
Ireland
Italy
Luxembourg
Malta
Netherlands
Norway	Numeta G13E
Poland
Portugal
Spain
United Kingdom

Documents
PAR:	https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016)
PARSummary:	https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016)
FinalSPC:	https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016)
FinalPL:	https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016)